3D Global Biotech Inc. (6808.TWO)
TWD 49.2
(0.51%)
TWD 49.2
(0.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -31.61 Million | -34.48 Million | -35.98 Million | -23.22 Million | -17.63 Million |
| Net Income | -58.91 Million | -83.13 Million | -60.96 Million | -48.47 Million | -36.31 Million |
| Depreciation & Amortization | 22.89 Million | 25.86 Million | 24.88 Million | 24.34 Million | 15.27 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 124 Thousand | 281 Thousand | 595 Thousand | 521 Thousand | 647 Thousand |
| Change in working capital | 4.29 Million | 3.64 Million | -769 Thousand | 62 Thousand | -319 Thousand |
| Other non-cash items | -2.06 Million | -1.43 Million | -1.08 Million | -1.6 Million | 3.07 Million |
| Investing Cash Flow | 33.58 Million | 18.19 Million | 52.29 Million | 19.77 Million | -120.29 Million |
| Investments in PPE | -778 Thousand | -856 Thousand | -2.88 Million | -30 Thousand | -35 Thousand |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -15 Million | - | - | - | -120.1 Million |
| Sales/Maturities of investments | 48.7 Million | 19.9 Million | 55.5 Million | 19.8 Million | - |
| Other Investing Activities | 661 Thousand | -849 Thousand | -325 Thousand | 19.8 Million | -120.26 Million |
| Financing Cash Flow | 4.31 Million | 11.45 Million | -4.36 Million | 3.17 Million | 126.02 Million |
| Debt repayment | -6.37 Million | -6.25 Million | -4.46 Million | -4.02 Million | -3.97 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 10.69 Million | 17.7 Million | - | 7.2 Million | - |
| Other Financing Activities | 10.69 Million | 17.7 Million | 105 Thousand | 7.2 Million | 130 Million |
| Accounts receivables | -253 Thousand | 136 Thousand | 417 Thousand | 368 Thousand | -837 Thousand |
| Accounts payables | 1.1 Million | - | - | - | - |
| Inventory | -225 Thousand | -2.48 Million | 259 Thousand | 36 Thousand | -527 Thousand |
| Other working capital | -1.41 Million | 2.92 Million | -1.18 Million | -123 Thousand | 1.04 Million |
| Cash at beginning of period | 15.53 Million | 20.37 Million | 8.43 Million | 8.71 Million | 20.62 Million |
| Cash at end of period | 21.81 Million | 15.53 Million | 20.37 Million | 8.43 Million | 8.71 Million |
| Capital Expenditure | -778 Thousand | -856 Thousand | -2.88 Million | -30 Thousand | -35 Thousand |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 6.28 Million | -4.84 Million | 11.94 Million | -282 Thousand | -11.91 Million |
| Free Cash Flow | -32.39 Million | -35.34 Million | -38.87 Million | -23.25 Million | -17.67 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -856.5 Thousand | -856.5 Thousand | -13.84 Million | -58.91 Million | -13.84 Million | -15.12 Million |
| Depreciation & Amortization | 5.6 Million | 5.6 Million | 5.64 Million | 22.89 Million | 5.64 Million | 5.72 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 20 Thousand | 124 Thousand | 20 Thousand | 42 Thousand |
| Change in working capital | -20.35 Million | -20.35 Million | 887.5 Thousand | 4.29 Million | 887.5 Thousand | -1.83 Million |
| Other non-cash items | 15.87 Million | 15.87 Million | 1.5 Million | -2.06 Million | 1.5 Million | 1.17 Million |
| Investing Cash Flow | -58.27 Million | -58.27 Million | 5.44 Million | 33.58 Million | 5.44 Million | 11.34 Million |
| Investments in PPE | -964 Thousand | -964 Thousand | -341.5 Thousand | -778 Thousand | -341.5 Thousand | -47.5 Thousand |
| Acquisitions | 45 Thousand | - | - | - | - | - |
| Investment purchases | -149.7 Million | - | - | -15 Million | - | - |
| Sales/Maturities of investments | 34.9 Million | - | - | 48.7 Million | - | - |
| Other Investing Activities | -57.31 Million | -57.31 Million | 5.78 Million | 661 Thousand | 5.78 Million | 11.39 Million |
| Financing Cash Flow | 80.81 Million | 80.81 Million | 2.69 Million | 4.31 Million | 2.69 Million | -538 Thousand |
| Debt repayment | - | - | - | -6.37 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 165 Million | - | - | 10.69 Million | - | - |
| Other Financing Activities | 80.81 Million | 80.81 Million | 2.69 Million | 10.69 Million | 2.69 Million | -538 Thousand |
| Accounts receivables | -414 Thousand | -414 Thousand | 1.26 Million | -253 Thousand | 1.26 Million | -1.39 Million |
| Accounts payables | 35.83 Million | - | - | - | - | - |
| Inventory | -19.56 Million | -19.56 Million | -166 Thousand | -225 Thousand | -166 Thousand | 53.5 Thousand |
| Other working capital | -372 Thousand | -372 Thousand | -215.5 Thousand | -1.41 Million | -215.5 Thousand | -493.5 Thousand |
| Cash at beginning of period | 21.81 Million | - | - | 15.53 Million | - | - |
| Cash at end of period | 22.8 Million | 22.8 Million | 2.35 Million | 21.81 Million | 2.35 Million | 790 Thousand |
| Capital Expenditure | -964 Thousand | -964 Thousand | -341.5 Thousand | -778 Thousand | -341.5 Thousand | -47.5 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 993 Thousand | 22.8 Million | 2.35 Million | 6.28 Million | 2.35 Million | 790 Thousand |
| Free Cash Flow | -699.5 Thousand | -699.5 Thousand | -6.12 Million | -32.39 Million | -6.12 Million | -10.06 Million |
9KF
AMBI
KKOYY
TDC
1090
BAROEXT